Type 1 diabetes

Predictors of Transitions From Glutamic Acid Decarboxylase Autoantibody (GADA) as the Initial Autoantibody to Multiple Autoantibodies of Type 1 Diabetes in Children at Risk by a Dynamic Prediction Model

Pediatr DiabetesPublished Prospective cohort study with dynamic prediction modelling

Authors' conclusion

The dynamic prediction model presented an individual time-specific risk of transition from a single GADA to multiple autoantibodies and type 1 diabetes.

Study context

Population
GADA-positive children at risk of T1D in the The Environmental Determinants of Diabetes in the Young (TEDDY) study, followed for additional autoantibodies (IAA, IA-2A, ZnT8A) and T1D
Participants
379 children
Outcome
Time of progression from single GADA to multiple islet autoantibodies and T1D
Methodological detailsdynamic prediction model, longitudinal risk variables
  • Dynamic prediction model
  • Longitudinal risk variables

Main finding

As reported in the abstract

Transition from GADA to multiple autoantibodies
Increased risk with lower age
p < 0.001
Increased risk with increased GADA titers during follow-up
p < 0.001
Less likely with HLA DQ2/X but not DQ2/8
p=0.004

Observational data: associations, not effects.

Further findings

Transition from multiple autoantibodies without IA-2A to IA-2A positivity

Associated with increased 2 h glucose after oral glucose tolerance test (OGTT)
P < 0.001
Associated with increased ZnT8A titers
P < 0.001

Transition from GADA only to T1D

Increased risk with increasing HbA1c
P < 0.001
Increased risk with increasing GADA titers
P < 0.001

Transition from multiple autoantibodies to T1D

Associated with increasing HbA1c
P < 0.001
Transition from multiple autoantibodies incl. IA-2A to T1D associated with 2 h glucose
P < 0.001

Original publication

Predictors of Transitions From GADA as the Initial Autoantibody to Multiple Autoantibodies of Type 1 Diabetes in Children at Risk by a Dynamic Prediction Model. Pediatr Diabetes. Published 16 September 2025. doi:10.1155/pedi/8845330

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.